Gregory J. Flesher
2022 - Reneo Pharmaceuticals
In 2022, Gregory J. Flesher earned a total compensation of $1.2M as President and Chief Executive Officer at Reneo Pharmaceuticals, a 78% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $245,300 |
|---|---|
| Option Awards | $393,000 |
| Salary | $545,000 |
| Other | $10,152 |
| Total | $1,193,452 |
Flesher received $545K in salary, accounting for 46% of the total pay in 2022.
Flesher also received $245.3K in non-equity incentive plan, $393K in option awards and $10.2K in other compensation.
Rankings
In 2022, Gregory J. Flesher's compensation ranked 2,639th out of 5,501 executives tracked by ExecPay. In other words, Flesher earned more than 52.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,639 out of 5,501 | 52nd |
Division Manufacturing | 1,461 out of 2,980 | 51st |
Major group Chemicals And Allied Products | 667 out of 1,335 | 50th |
Industry group Drugs | 620 out of 1,238 | 50th |
Industry Pharmaceutical Preparations | 443 out of 892 | 50th |
Source: SEC filing on April 26, 2023.
Flesher's colleagues
We found two more compensation records of executives who worked with Gregory J. Flesher at Reneo Pharmaceuticals in 2022.
News
Reneo Pharmaceuticals CEO Gregory Flesher's 2022 pay falls 78% to $1.2M
April 26, 2023
Reneo Pharmaceuticals CEO Gregory Flesher's 2021 pay jumps 3,939% to $5.4M
April 22, 2022
Tokai Pharmaceuticals CEO Gregory Flesher's 2019 pay slips 11% to $843K
March 31, 2020
Tokai Pharmaceuticals CEO Gregory Flesher's 2018 pay slips 2% to $943K
May 15, 2019